Fundz

Fundz Deep Dive

Everything you need to win Tevogen Bio — in one platform.

Who to reach, what to say, and why now on Tevogen Bio — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Tevogen Bio — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Tevogen Bio Enters $10 Million Grant Funding Partnership

Feb 17, 2025over 1 year ago

Contract Type

partnership

WarrenBiotechnologySoftwareData And AnalyticsHealth CareTherapeutics

Description

Tevogen Bio shares a summary of the Company’s 2024 financing activity at the one year anniversary of being listed on the Nasdaq exchange. Additionally, on January 28, 2025, Tevogen Bio entered into an agreement to receive up to $10 million in grant funding, $2 million of which has already been received, with the potential for an additional $8 million based on the grantor’s review of the Company’s activities. This grant funding is not dilutive to existing Tevogen Bio shareholders, and may enable R&D efforts and accelerate advancements in Tevogen.AI.

Company Information

Company

Tevogen Bio

Location

Warren, New Jersey, United States

About

Tevogen Bio brings together a highly skilled team of preeminent scientists, senior biopharmaceutical leaders, and manufacturing experts with the goal of advancing global health. The company’s patient centric mission is to leverage its proprietary cell and gene therapy platforms and novel business model to rapidly innovate breakthrough immunotherapies for cancers and viral infections with high unmet need. Tevogen Bio’s foundational vision is a healthier world through equitable access to lifesaving innovations.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Tevogen Bio's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.